Dr. Elizabeth Placzek, a pediatrician at Children’s Minnesota, explains how childhood vaccines are proven to be safe and effective at reducing serious illness and more.
There are two new FDA-approved options to prevent respiratory syncytial virus (RSV) in infants: a maternal RSV vaccine (Abrysvo) and a monoclonal antibody (nirsevimab; Beyfortus).
Respiratory syncytial virus (RSV) is a major cause of respiratory illness in babies and young children every year from late fall to early spring. Learn
Get information about where to get care for your child if they are experiencing respiratory illnesses like influenza, COVID-19 and respiratory syncytial virus (RSV).
Jordan and Jaare noticed their 5-week-old baby had labored breathing and later found out he had RSV at Children’s Minnesota. They dedicate much of their
Dr. Lia Gravari, a neonatologist at Children’s Minnesota, provided her expert insights about neonatal pneumonia, one of the leading causes of neonatal respiratory distress in
Reach us 24/7 for patient referrals, consults, admissions and neonatal transport.
© 2024 Children’s Minnesota
Children’s Minnesota is registered as a 501(c)(3) non-profit organization. Our tax identification number is 41-1754276.
